Literature DB >> 9674738

Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome.

D Zicha1, W E Allen, P M Brickell, C Kinnon, G A Dunn, G E Jones, A J Thrasher.   

Abstract

Wiskott-Aldrich syndrome (WAS) is a rare disease characterized by microthrombocytopenia, eczema and immune deficiency. In this study a direct-viewing chemotaxis chamber was used to analyse chemotactic responses of WAS neutrophils and macrophages in stable linear concentration gradients. In five patients with classic WAS, chemotaxis of macrophages but not of neutrophils was found to be abolished, whereas the speed of random motility of both cell types was found to be indistinguishable from control cells. This supports the existence of an essential functional link, previously suggested by biochemical studies, between Cdc42, WAS protein (WASp) and the actin cytoskeleton in primary human macrophages. Moreover, these data suggest that Cdc42-WASp-mediated filopodial extension is a requirement for chemotaxis but not for chemokinesis in these cells. Abnormal directional cell motility of macrophages and related antigen-presenting cells may play a significant part in the immune deficiency and eczema of WAS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674738     DOI: 10.1046/j.1365-2141.1998.00767.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  71 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  The Wiskott-Aldrich syndrome.

Authors:  A J Thrasher; C Kinnon
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

3.  A WASp-VASP complex regulates actin polymerization at the plasma membrane.

Authors:  F Castellano; C Le Clainche; D Patin; M F Carlier; P Chavrier
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 4.  Ophthalmic manifestations of immunodeficiency states.

Authors:  R Rescigno; M Dinowitz
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

5.  Src-mediated phosphorylation of mammalian Abp1 (DBNL) regulates podosome rosette formation in transformed fibroblasts.

Authors:  Lindsy R Boateng; Christa L Cortesio; Anna Huttenlocher
Journal:  J Cell Sci       Date:  2012-02-02       Impact factor: 5.285

6.  Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis.

Authors:  Sundaram Ramasamy; Deanna D Nguyen; Michelle A Eston; Sayeda Nasrin Alam; Angela K Moss; Farzad Ebrahimi; Brishti Biswas; Golam Mostafa; Kathryn T Chen; Kanakaraju Kaliannan; Halim Yammine; Sonoko Narisawa; José Luis Millán; H Shaw Warren; Elizabeth L Hohmann; Emiko Mizoguchi; Hans-Christian Reinecker; Atul K Bhan; Scott B Snapper; Madhu S Malo; Richard A Hodin
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

Review 7.  Wiskott-Aldrich syndrome: another piece in the puzzle.

Authors:  L D Notarangelo; L Mori
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

8.  The HIV-1 coat protein gp120 regulates CXCR4-mediated signaling in neural progenitor cells.

Authors:  Phuong B Tran; Dongjun Ren; Richard J Miller
Journal:  J Neuroimmunol       Date:  2004-12-28       Impact factor: 3.478

9.  Arp2/3 Complex Is Required for Macrophage Integrin Functions but Is Dispensable for FcR Phagocytosis and In Vivo Motility.

Authors:  Jeremy D Rotty; Hailey E Brighton; Stephanie L Craig; Sreeja B Asokan; Ning Cheng; Jenny P Ting; James E Bear
Journal:  Dev Cell       Date:  2017-08-31       Impact factor: 12.270

10.  NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma.

Authors:  C A Murga-Zamalloa; V Mendoza-Reinoso; A A Sahasrabuddhe; D Rolland; S R Hwang; S R P McDonnell; A P Sciallis; R A Wilcox; V Bashur; K Elenitoba-Johnson; M S Lim
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.